Skip to main content

Volume Deficit in the Hand

0
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Galderma
GaldermaTX - Dallas
1 program
Restylane Lyft with LidocaineN/A2 trials
Active Trials
NCT07566286Not Yet Recruiting100Est. Feb 2028
NCT02650921Completed92Est. Dec 2016

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
GaldermaRestylane Lyft with Lidocaine
GaldermaRestylane Lyft with Lidocaine

Clinical Trials (2)

Total enrollment: 192 patients across 2 trials

NCT07566286GaldermaRestylane Lyft with Lidocaine

Study to Evaluate the Safety of Retreatment With Restylane® Lyft With Lidocaine for Augmentation of the Chin Region

Start: Jun 2026Est. completion: Feb 2028100 patients
N/ANot Yet Recruiting
NCT02650921GaldermaRestylane Lyft with Lidocaine

Effectiveness and Safety of Restylane Lyft With Lidocaine in the Dorsal Hand

Start: Dec 2015Est. completion: Dec 201692 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.